Browsing by Author Nakou, E. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 9 of 9
TitleAuthor(s)Issue date
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Nakou, E. S.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemiaNakou, E. S.; Filippatos, T. D.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemiaNakou, E. S.; Filippatos, T. D.; Kiortsis, D. N.; Derdemezis, C. S.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patientsNakou, E. S.; Filippatos, T. D.; Agouridis, A. P.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015
Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic SyndromeDerdemezis, C. S.; Filippatos, T. D.; Nakou, E. S.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemiaFlorentin, M.; Kostapanos, M. S.; Nakou, E. S.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015
Orlistat-associated adverse effects and drug interactions: a critical reviewFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Nakou, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
The role of C-reactive protein in atherosclerotic cardiovascular disease: an overviewNakou, E. S.; Liberopoulos, E. N.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015